Multiplex Detection of Cell Surface Biomarkers: Targeting Estrogen Receptor (ER), Progesterone Receptor (PR), HER2, CA 15-3, CA 27.29, and CEA in Cancer Diagnosis
Received Date: Jan 02, 2024 / Published Date: Jan 29, 2024
Abstract
Accurate detection and characterization of biomarkers on the cell surface play a crucial role in the diagnosis and treatment of various cancers. This study focuses on the multiplex detection of key biomarkers including Estrogen Receptor (ER), Progesterone Receptor (PR), Human Epidermal Growth Factor Receptor 2 (HER2), Cancer Antigen 15-3 (CA 15-3), Cancer Antigen 27.29 (CA 27.29), and Carcinoembryonic Antigen (CEA) in cancer samples. A comprehensive approach utilizing advanced molecular techniques is employed to simultaneously assess the expression levels of these biomarkers. The development of a multiplex detection platform allows for rapid and sensitive analysis, enabling clinicians to obtain valuable insights into the molecular profile of tumors. This research contributes to the advancement of personalized medicine by facilitating the identification of suitable therapeutic strategies tailored to individual patients based on their specific biomarker profiles.
Citation: Smith J (2024) Multiplex Detection of Cell Surface Biomarkers: TargetingEstrogen Receptor (ER), Progesterone Receptor (PR), HER2, CA 15-3, CA 27.29,and CEA in Cancer Diagnosis. J Cancer Diagn 8: 223.
Copyright: © 2024 Smith J. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Usage
- Total views: 220
- [From(publication date): 0-2024 - Nov 22, 2024]
- Breakdown by view type
- HTML page views: 178
- PDF downloads: 42
